2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Prostatic Neoplasms
4
Urinary Bladder Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Disease
2
Colorectal Neoplasms
2
Acute Kidney Injury
2
Tuberous Sclerosis
1
Spinal Cord Injuries
1
Smoldering Multiple Myeloma
1
Salivary Gland Adenoma, Pleomorphic
1
Renal Insufficiency
1
Prostatic Hyperplasia
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphangioleiomyomatosis
1
Liver Cirrhosis
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Hemangiosarcoma
1
Glioma
1
Gallbladder Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Pancreatic Ductal
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Peripheral Blood Stem Cell Transplantation
4
Cyclophosphamide
4
fludarabine phosphate
3
Epoetin Alfa
3
Darbepoetin alfa
3
Curcumin
3
liposomal amphotericin B
2
Whole-Body Irradiation
2
Tacrolimus
2
Mycophenolic Acid
2
Morphine
2
Microarray Analysis
2
Methylprednisolone
2
Interferon-alpha
2
In Situ Hybridization, Fluorescence
2
Filgrastim
2
Fentanyl
2
Cytogenetic Analysis
2
Cyclosporine
2
Caspofungin
2
Carboplatin
2
Busulfan
2
Bortezomib
2
Biopsy
2
Antilymphocyte Serum
2
tanespimycin
1
siltuximab
1
sargramostim
1
pyroxamide
1
piperine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Monoclonal Gammopathy of Undetermined Significance
×
Urination
×
Clear all
NCT03951220
2025-08-19
LOOMIS
Oxford University Hospitals NHS Trust
Completed
67 enrolled
24 charts